Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

John Ziegler, Dianabol & the Cold War

The Olympic-Era Origins of Anabolic Steroids

Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Methandrostenolone (Dianabol), withdrawn in U.S.; AAS are Schedule III
WADA
Prohibited (S1 Anabolic Agent)

Reference only. Not medical advice.

What can go wrong

Supraphysiological anabolic-steroid use is associated with cardiovascular disease, liver toxicity (especially oral 17-alpha-alkylated agents like Dianabol), suppression of natural testosterone, testicular atrophy, infertility, gynecomastia, and mood disturbance. AAS are banned in sport and controlled by law.

This is something to take to a clinician. The Atlas can tell you what is known about john ziegler, dianabol & the cold war in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Methandrostenolone, marketed as Dianabol by Ciba Pharmaceuticals from 1958, was developed in collaboration with U.S. Olympic team physician John Bosley Ziegler, who sought an anabolic agent with reduced androgenic effects after learning Soviet weightlifters were using testosterone. Ziegler introduced it to American weightlifters around 1959. Dianabol launched the modern anabolic-steroid era in sport, and Ziegler later expressed regret as he saw the drugs abused and their harms emerge.

How the steroid era began at a Cold War weightlifting meet.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Performance enhancement in weightlifting and bodybuilding (the historical, now-banned use)
  • Originally framed as an anabolic agent with reduced androgenicity

How it is supposed to work

Methandrostenolone is a synthetic, orally active derivative of testosterone engineered for high anabolic relative to androgenic activity, promoting muscle protein synthesis and nitrogen retention at supraphysiological doses.

Safety in detail

Anabolic-androgenic steroids involve significant physiological effects and serious documented health risks. Non-medical use is illegal in many jurisdictions. Any legitimate androgen therapy requires evaluation and monitoring by a qualified physician.

Replacement is not the same as a cycle

Dianabol was used at supraphysiological, performance-enhancing doses far above any replacement level. Physiological testosterone replacement aims to restore normal hormone levels in deficient men under medical supervision; supraphysiological anabolic dosing for muscle gain carries markedly higher cardiovascular, hepatic, endocrine, and fertility risks.

What it does to fertility

Supraphysiological anabolic-steroid use suppresses the hypothalamic-pituitary-gonadal axis, reducing sperm production and frequently causing testicular atrophy and infertility, sometimes persistently after discontinuation.

What people get wrong

  • Often saidDianabol was a safer steroid

    ActuallyIt was designed to be less androgenic, but supraphysiological use still causes serious cardiovascular, hepatic, endocrine, and fertility harm. Ziegler himself came to regret promoting it.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

How we got here

The modern anabolic-steroid era traces to the Cold War rivalry of Olympic weightlifting. According to widely told accounts, at the 1954 World Weightlifting Championships, U.S. team physician John Bosley Ziegler learned from the Soviet team's doctor that their lifters were using testosterone. Recognizing both its performance benefit and its androgenic side effects, Ziegler worked with Ciba Pharmaceuticals to develop an agent that retained anabolic (muscle-building) potency while reducing androgenic effects. The result was methandrostenolone, which Ciba marketed as Dianabol beginning in 1958. Ziegler began administering it to American weightlifters, including lifters at the York Barbell Club, around 1959, and its use spread rapidly through strength sports and then bodybuilding. Ziegler reportedly grew alarmed as he witnessed athletes self-administering far beyond any reasonable dose and developing complications such as prostate enlargement and testicular atrophy. He came to regret his role in introducing the drugs. Dianabol and its successors fueled decades of doping; anabolic-androgenic steroids were eventually banned in sport and, in the United States, classified as Schedule III controlled substances under the Anabolic Steroids Control Act of 1990. Dianabol itself was withdrawn from the U.S. market, but the era it launched permanently shaped the relationship between testosterone, sport, and risk.

  1. 1954Ziegler reportedly learns of Soviet testosterone use at the World Weightlifting Championships
  2. 1958Ciba markets methandrostenolone as Dianabol
  3. 1959Ziegler gives it to U.S. weightlifters (York Barbell)
  4. 1960s-70sAAS use spreads through strength sports and bodybuilding
  5. 1976IOC begins testing for anabolic steroids
  6. 1990U.S. Anabolic Steroids Control Act makes AAS Schedule III

At a glance

Compound
Methandrostenolone (Dianabol)
Marketer
Ciba Pharmaceuticals, 1958
Key figure
Dr. John Bosley Ziegler, U.S. weightlifting team physician
Cold War context
Response to Soviet testosterone use in weightlifting
First U.S. athletic use
~1959 (York Barbell lifters)
Legal status now
U.S. Schedule III controlled substance; WADA-banned

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about John Ziegler, Dianabol & the Cold War. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Introduction of methandrostenolone (Dianabol) in sport1958-1959

    Marked the beginning of the modern anabolic-steroid era in athletics